Effect of 17-β-estradiol on dopamine, serotonine and GABA striatal levels in 6-hydroxydopamine-treated rats

Toxicology

Volumn 204, Issue 2-3, 2004, Pages 155-160

  Peinado, Virginia ^a   González, José Carlos ^a   Leret, Mariá Luisa ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Dopamine; GABA.; Oestrogens; Oxidative stress; Serotonin

Indexed keywords

4 AMINOBUTYRIC ACID; DOPAMINE; ESTRADIOL; NEUROPROTECTIVE AGENT; NEUROTRANSMITTER; OXIDOPAMINE; SEROTONIN;

4 AMINOBUTYRIC ACID BRAIN LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN PROTECTION; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DOPAMINERGIC NERVE CELL; DRUG EFFECT; FEMALE; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RAT; SEROTONIN BRAIN LEVEL;

ANIMALS; CORPUS STRIATUM; DOPAMINE; ESTRADIOL; FEMALE; GAMMA-AMINOBUTYRIC ACID; OVARIECTOMY; OXIDOPAMINE; RATS; RATS, WISTAR; SEROTONIN;

EID: 4544220644     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2004.06.021     Document Type: Article

References (36)

1. L.M. Ambani, M.H. Van Woert, and S. Murphy Brain peroxidase and catalase in Parkinson disease Arch. Neurol. 32 1975 114 118
2. B receptors in the rat substantia nigra Neurosci. Lett. 325 2002 33 36
3. C. Behl, T. Skutella, F. Lezoualc'h, A. Post, M. Widmann, C.J. Newton, and F. Holsboer Neuroprotection against oxidative stress by estrogens: structure-activity relationship Mol. Pharmacol. 51 1997 535 541
4. R. Bossé, R. Rivest, and T. Di Paolo Ovariectomy and estradiol treatment affect the dopamine transporter and its gene expression in the rat brain Mol. Brain Res. 46 1997 343 346
5. R.D. Briton, J. Tran, P. Proffitt, and M. Montoya 17-beta-Estradiol enhances the outgrowth and survival of neocortical neurons is culture Neurochem. Res. 22 1997 1339 1351
6. M. Camp, and A. Carlsson A regional study of sex differences in rat brain serotonin Prog. Neuropsychoph. Biol. Psychiat. 12 1986 53 61
7. B.B. Carlsson, Behrstock, A.J. Tobin, and J.D. Salamone Brain implantations of engineered GABA-releasing cells suppress tremor in an animal model of parkinsonism Neuroscience 119 2003 927 932
8. P. Damier, E.C. Hirsch, P. Zhang, Y. Agid, and F. Javoy-Agid Gluthathione peroxidase, glial cells and Parkinson's disease Neuroscience 52 1993 1 6
9. S. Desagher, and J.C. Martinou Mitochondria as the central control point of apoptosis Trends Cell Biol. 10 2000 369 377
10. D.T. Dexter, A. Carayon, M. Vidailhet, M. Ruberg, F. Agid, Y. Agid, A.J. Lees, F.R. Wells, P. Jenner, and C.D. Marsden Decreased ferritin levels in brain in Parkinson's disease J. Neurochem. 55 1990 16 20
11. D.E. Dluzen, and J.L. McDermott Neuro-protective role of estrogen upon metauphetamine and related neurotoxins within the nigroestriatal dopaminergic system Ann. New York Acad. Sci. 914 2000 112 126
12. 2 and ATP production and on dopamine and DOPAC in the striatum J. Physiol. Biochem. 55 1999 325 332
13. S. Fahn, and G. Cohen The oxidant stress hypothesis in Parkinson's disease: evidence supporting it Ann. Neurol. 32 1992 804 812
14. 3H]GABA release in slices of the rat thalamic reticular nucleus Neuropharmacology 46 2004 497 503
15. P.S. Green, J. Bishop, P. Simpkins, and M. Montoya 17-α-Estradiol exerts neuroprotective effects in SK-N-SH cells J. Neurosci. 17 1997 511 515
16. P.S. Green, K.E. Gridley, and J.W. Simpkins Estradiol protects against β-amiloid (25-35)-induced toxicity in SK-N-SH cells Neurosci. Lett. 218 1996 165 168
17. P.S. Green, K.E. Gridley, and J.W. Simpkins Nuclear estrogen receptor-independent neuroprotection by estratrienes: a novel interaction with glutathione Neuroscience 84 1998 7 10
18. P.S. Green, and J.W. Simpkins Neuroprotective effects of estrogens: potential mechanism of action Int. J. Dev. Neurosci. 18 2000 347 358
19. E.C. Hirsch, B. Faucheux, P. Damier, A. Mouatt-Prigent, and Y. Agid Neuronal vulnerability in Parkinson's disease J. Neural Transm. 50 1997 79 88
20. K. Jellinger, E. Kienzl, G. Rumpelmair, P. Riederer, H. Stachelberger, D. Ben Sachar, and M.B. Youdim Iron-melanin complex in substantia nigra in Parkinsonian brains: an X-ray microanalysis J. Neurochem. 59 1992 1168 1171
21. P. Jenner, D.T. Dexter, J. Sian, A.H. Schapira, and C.D. Marsden Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease, The Royal Kings and Queens Parkinson's Disease Research Group Ann. Neurol. 32 1992 82 87
22. M.L. Leret, J.A. San Millán, E. Fabre, R. Gredilla, and G. Barja Deprenyl protects from MPTP-induced Parkinson-like syndrome and glutathione oxidation in rat striatum Toxicology 170 2002 165 171
23. G. Levay, and W.J. Bodell Detection of dopamine-DNA adducts: potential role in Parkinson's disease Carcinogenesis 14 1993 1241 1245
24. J.J. Liaw, J.R. He, R.D. Hartman, and C.A. Barraclough Changes in tyrosine hydroxylase RNA levels in medullary A1 and A2 neurons and locus coeruleus following castration and oestrogen replacement in rats Mol. Brain. Res. 13 1992 213 238
25. J.C. Miller Sex differences in dopaminegic and cholinergic activity and function in the nigro-striatal system of the rat Psychoneuroendocrinology 8 1983 225 236
26. F. Molina-Holgado, M.I. González, and M.L. Leret Effect of D9-tetrahydrocannabinol on short-term memory in the rat Physiol. Behav. 57 1995 177 179
27. A.D. Mooradian Antioxidant properties of steroids J. Steroid Biochem. Mol. Biol. 45 1993 509 511
28. B. Moosman, and C. Behl The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties Proc. Natl. Acad. Sci. U.S.A. 96 1999 8867 8872
29. C. Pasqualini, V. Olivier, B. Guibert, O. Frain, and V. Leviel Acute stimulatory effects of estradiol on striatal dopamine synthesis J. Neurochem. 65 1995 1651 1657
30. G. Paxinos, and C. Watson The Rat Brain Stereotaxic Coordinates 1982 Academic Press New York
31. V.D. Ramírez Hormones and striatal dopaminergic activity: a novel neuroendocrine model A.S. Bhatnagar The Anterior Pituitary Gland 1983 Raven Press New York 97 145
32. T.M. Saleh, B.J. Conell, T. McQuaid, and A.E. Crib Estrogen-induced neurochemical and electrophysiological changes in the parabrachial nucleus of the male rat Brain Res. 990 2003 58 65
33. J.K. Seamans, N. Gorelova, D. Durstewitz, and C.R. Yang Bidirectional dopamine modulation of GABAergic inhinition in prefrontal cortical pyramidal neurons J. Neurosci. 21 2001 3628 3638
34. R.B. Simerly, and B.J. Young Regulation of estrogen receptor messenger ribonucleic acid in rat hypothalamus by sex steroid hormones Mol. Endocrinol. 5 1991 424 432
35. J. Trevitt, B.B. Carlsson, M. Correa, A. Keene, M. Morales, and J.D. Salamone Interactions between dopamine D1 receptors and GABA mechanisms in substantia nigra pars reticulata: neurochemical and behavioral studies Psychopharmacology 159 2002 229 237
36. G.R. Uhl Hypothesis: the role of dopaminergic transporters in selective vulnerability of cells in Parkinson's disease Ann. Neurol. 43 1998 555 560